Paul Bleicher, MD, PhD

Chief Executive Officer


Paul Bleicher, MD, PhD, is the CEO of OptumLabs.   

Prior to OptumLabs, Dr. Bleicher was Chief Medical Officer for Humedica, a next-generation clinical informatics company. He also co-founded and was a leader at Phase Forward, which was instrumental in transforming pharmaceutical clinical trials from paper to the web.

Dr. Bleicher has served as a leader in such notable industry associations as the National Academy of Medicine’s Leadership Consortium for Value & Science-Driven Health Care and the Drug Information Association. He has received numerous awards for his industry leadership.

Dr. Bleicher holds a BS from Rensselaer, as well as an MD and PhD from the University of Rochester School of Medicine and Dentistry. He began his career as a physician/investigator and assistant professor at the Massachusetts General Hospital and Harvard Medical School.